1. A public health approach to the diabetes epidemic: New York city’s diabetes registry

   • Mary Ann Banerji
   • Robyn B. Stewart

   Invited Commentary Pages: 169 - 171

2. Web alert

   News Pages: 172 - 173

3. Fatty acid—induced inflammation and insulin resistance in skeletal muscle and liver

   • Guenther Boden

   OriginalPaper Pages: 177 - 181

4. Development of type 2 diabetes in children and adolescents

   • Ram Weiss
   • Sara E. Taksali
   • Sonia Caprio

   OriginalPaper Pages: 182 - 187

5. Central nervous system and control of endogenous glucose production

   • Giovanna Demuro
   • Silvana Obici

   OriginalPaper Pages: 188 - 193

6. Incretins and the development of type 2 diabetes

   • Juris J. Meier
   • Michael A. Nauck

   OriginalPaper Pages: 194 - 201

7. The dream trial and the prospect of diabetes prevention

   • Samy I. McFarlane
   • Tanja Rundek
   • James R. Sowers

   Clinical Trials Report Pages: 205 - 206

8. Cardiometabolic syndrome and chronic kidney disease

   • Guido Lastra
   • Camila Manrique
   • James R. Sowers

   OriginalPaper Pages: 207 - 212

9. Anemia and cardiovascular disease in diabetic nephropathy

   • Samy I. McFarlane
   • Moro O. Salifu
   • James R. Sowers

   OriginalPaper Pages: 213 - 218

10. Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome

    • Pantelis A. Sarafidis
    • Samy I. McFarlane
    • George L. Bakris

    OriginalPaper Pages: 219 - 224

11. Clinical trials report

    • Mary Ann Banerji
    • Mustafa Tiewala

    BriefCommunication Pages: 227 - 229

12. Treatment of hypertriglyceridemia

    • Warren H. Capell
    • Robert H. Eckel

    OriginalPaper Pages: 230 - 240

13. Type 2 diabetes and the metabolic syndrome in children and adolescents

    • José F. Cara
    • Rochelle L. Chaiken

    OriginalPaper Pages: 241 - 250

14. The role of complementary and alternative medicine in diabetes

    • Shefali Dham
    • Viral Shah
    • Mary Ann Banerji

    OriginalPaper Pages: 251 - 258